ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 941,64
0,88%
Dow Jones
44 877,75
0,37%
DAX
21 727,20
0,48%
Brent Oil
75,97
0,07%
Bitcoin
105 219,15
1,43%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Acurx Pharmaceuticals Inc (ACXP) Cours

Acurx Pharmaceuticals Inc

Acurx Pharmaceuticals Inc (ACXP)

NASDAQ
0,72
-0,01
( -1,37% )
Mis à jour : 18:59:35
Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
0,72
Prix Achat
0,72
Prix Vente
0,7257
Volume échangé
86 728
0,71 Fourchette du Jour 0,7401
0,68 Plage de 52 semaines 3,77
Cap du marché
12,163M
Clôture Veille
0,73
Ouverture
0,74
Dernière Transaction
100
@
0.72
Dernière heure de transaction
19:00:44
Volume financier
US$ 62 706
VWAP
0,723015
Volume moyen (3 m)
299 465
Actions en circulation
16 892 548
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,83
Bénéfice par action (BPA)
-0,86
Chiffre d'affairess
-
Bénéfice net
-14,58M

À propos de Acurx Pharmaceuticals Inc

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.acurxpharma.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Acurx Pharmaceuticals Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker ACXP. Le dernier cours de clôture d'Acurx Pharmaceuticals était de US$0,73. Au cours de la dernière année, les actions de Acurx Pharmaceuticals ont été négociées dans une fourchette de prix de US$ 0,68 à US$ 3,77.

Acurx Pharmaceuticals compte actuellement 16 892 548 actions en circulation. La capitalisation boursière d'Acurx Pharmaceuticals est de US$12,33 million. Acurx Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de -0.83.

ACXP Dernières nouvelles

Plus de nouvelles

Form 4 - Statement of changes in beneficial ownership of securities

08 Janvier 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

08 Janvier 2025
Edgar (US Regulatory)

Acurx Pharmaceuticals, Inc. Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Acurx Pharmaceuticals, Inc. Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules PR Newswire STATEN ISLAND, N.Y., Jan. 7, 2025 STATEN ISLAND, N.Y...

07 Janvier 2025
PR Newswire (US)

Form 424B5 - Prospectus [Rule 424(b)(5)]

07 Janvier 2025
Edgar (US Regulatory)

Form 8-K - Current report

07 Janvier 2025
Edgar (US Regulatory)

Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules PR Newswire STATEN ISLAND, N.Y., Jan. 6, 2025 STATEN ISLAND, N.Y., Jan. 6...

06 Janvier 2025
PR Newswire (US)

Form 424B3 - Prospectus [Rule 424(b)(3)]

06 Janvier 2025
Edgar (US Regulatory)

Acurx Receives Positive Regulatory Guidance from EMA for Ibezapolstat Phase 3 Program for C. Difficile Infection (CDI)

Acurx Receives Positive Regulatory Guidance from EMA for Ibezapolstat Phase 3 Program for C. Difficile Infection (CDI) PR Newswire STATEN ISLAND, N.Y., Jan. 6, 2025 Acurx has now received...

06 Janvier 2025
PR Newswire (US)

Acurx Updates Phase 3 Readiness for Ibezapolstat in C. difficile Infection Based on Recent FDA and EMA Communications

Acurx Updates Phase 3 Readiness for Ibezapolstat in C. difficile Infection Based on Recent FDA and EMA Communications PR Newswire STATEN ISLAND, N.Y., Dec. 9, 2024 Following the previously...

09 Décembre 2024
PR Newswire (US)

Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset

Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset PR Newswire STATEN ISLAND, N.Y., Nov. 20, 2024 STATEN ISLAND, N.Y., Nov. 20, 2024 /PRNewswire/ -- Acurx Pharmaceuticals, Inc...

20 Novembre 2024
PR Newswire (US)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.1103-13.28435505240.83030.87160.7041155650.78925272CS
4-0.129-15.19434628980.8491.250.685309810.82891487CS
12-1.14-61.29032258061.861.90.682994650.93244706CS
26-1.53-682.252.390.681577761.12115579CS
52-2.98-80.54054054053.73.770.681182361.57761326CS
156-3.28-8248.820.681333232.93001223CS
260-5.23-87.89915966395.958.820.681512293.83599603CS

ACXP - Frequently Asked Questions (FAQ)

What is the current Acurx Pharmaceuticals share price?
The current share price of Acurx Pharmaceuticals is US$ 0,72
How many Acurx Pharmaceuticals shares are in issue?
Acurx Pharmaceuticals has 16 892 548 shares in issue
What is the market cap of Acurx Pharmaceuticals?
The market capitalisation of Acurx Pharmaceuticals is USD 12,33M
What is the 1 year trading range for Acurx Pharmaceuticals share price?
Acurx Pharmaceuticals has traded in the range of US$ 0,68 to US$ 3,77 during the past year
What is the PE ratio of Acurx Pharmaceuticals?
The price to earnings ratio of Acurx Pharmaceuticals is -0,83
What is the reporting currency for Acurx Pharmaceuticals?
Acurx Pharmaceuticals reports financial results in USD
What is the latest annual profit for Acurx Pharmaceuticals?
The latest annual profit of Acurx Pharmaceuticals is USD -14,58M
What is the registered address of Acurx Pharmaceuticals?
The registered address for Acurx Pharmaceuticals is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the Acurx Pharmaceuticals website address?
The website address for Acurx Pharmaceuticals is www.acurxpharma.com
Which industry sector does Acurx Pharmaceuticals operate in?
Acurx Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
FOXXFoxx Development Holdings Inc
US$ 8,75
(202,77%)
21M
AMODAlpha Modus Holdings Inc
US$ 3,7399
(142,85%)
111,9M
ACONAclarion Inc
US$ 20,84
(126,21%)
2,14M
TECXTectonic Therapeutic Inc
US$ 51,58
(100,54%)
4,13M
NAOVNanoVibronix Inc
US$ 0,593
(54,63%)
79,06M
CLEUChina Liberal Education Holdings Ltd
US$ 0,2435
(-96,86%)
169,88M
CRGXCARGO Therapeutics Inc
US$ 3,38
(-74,37%)
16,31M
EVTVEnvirotech Vehicles Inc
US$ 0,38
(-43,03%)
3,07M
FATFAT Brands Inc
US$ 3,4257
(-41,64%)
201,47k
ZKINZK International Group Co Ltd
US$ 0,2995
(-38,31%)
1,96M
NVDANVIDIA Corporation
US$ 120,025
(-2,97%)
203,42M
CLEUChina Liberal Education Holdings Ltd
US$ 0,2435
(-96,86%)
169,88M
MGOLMGO Global Inc
US$ 0,12
(17,99%)
142,29M
AMODAlpha Modus Holdings Inc
US$ 3,7399
(142,85%)
111,9M
SPGCSacks Parente Golf Inc
US$ 0,81
(37,29%)
103,94M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
ACXP
Acurx Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces